卓能(集團)(00131.HK):預計年度收入同比大幅減少約9億港元
格隆匯8月22日丨卓能(集團)(00131.HK)公佈,集團預期(i)將會於截至2022年6月30日止年度錄得收入較截至2021年6月30日止年度大幅減少約9億港元;(ii)毛利將會較2021財政年度的毛利減少約7.3億港元,並可能會於2022財政年度錄得輕微毛損;及(iii)將會於2022財政年度錄得公司持有人應占虧損(未計及投資物業公允價值之變動前)約6000萬港元,相比之下,於2021財政年度為公司持有人應占溢利(未計及投資物業公允價值之變動前),有關原因為誠如上文所述於2022財政年度之毛利下降以及集團於2022財政年度之其他收入、行政費用及所得税支出較2021財政年度減少之共同影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.